Clinuvel Pharmaceuticals Limited American Depositary Shares

CUVLNASDAQ • USD
4.87 USD
↘ 0.03 (0.59%)🟢LIVE (AS OF 10:26 AM EST)
🟢Market: OPEN

Clinuvel Pharmaceuticals Limited American Depositary Shares (CUVL) is currently trading at $4.87. Technical indicators currently signal "Strong Sell". Notable factors include a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment.

Technical & fundamental data as of Nov 17, 2026.

Open?$4.92
High?$5.06
Low?$4.87
Prev. Close?$4.90
Volume?73
Avg. Volume?N/A
VWAP?$4.97
Bid / Ask
Bid?$5.65 × 200
Ask?$5.79 × 100
Spread?$0.14
Midpoint?$5.72
Valuation & Ratios
Market Cap?247.4M
Shares Out?50.5M
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Clinuvel Pharmaceuticals Ltd is a biopharmaceutical firm focused on developing and delivering therapies for patients with genetic, metabolic, and dermatological disorders. Its portfolio is centred around melanocortin peptides, with programs advancing in photomedicine and vitiligo. The company's main therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the U.S.A., Canada, Israel, and Australia as a systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). Additionally, the firm is focused on developing and manufacturing Neuracthel to target neurological, endocrinological, and degenerative disorders. Geographically, it derives key revenue from Ireland.
Employees
100
Market Cap
247.4M
Industry
N/A
Listed
2004-06-30
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestLow
Short Interest?1.9K
Days to Cover?1.0
Avg Daily Volume6.4K
Settlement Date2026-10-30